A Pilot Study to Assess the Impact of Breath Awareness Using Pyramid on Symptoms of Anxiety and Depression in People with T2DM

Recruiting N/A Interventional Study
Depression, Anxiety
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 80
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
152 (estimated)
Sponsor
Dasman Diabetes Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Diabetes mellitus is rampant in the Middle East. It is a psychologically and behaviorally demanding disease; psychosocial factors are relevant to nearly all aspects of its management. Moreover, depression and diabetes are bidirectionally connected. Those with depression are at risk of developing diabetes and those with comorbid diabetes are at risk of developing depressive symptoms. Research findi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: • More than 1 year of T2DM diagnosis * T2DM with HbA1c greater than 5.7 and less than 9.5% * T2DM patients, age greater than 30 years and on oral hypoglycaemic agents or on insulin * No cardiac problems * Score 8.0 and above as per the anxiety and depression questionnaires. * Ab…
Contacts

Rashmi Shiju, MPharmacy

22242999

rashmi.shiju@dasmaninstitute.org

CONTACT

Abdullah Bennakhi, MD

22242999

abdullah.bennakhi@dasmaninstitute.org

CONTACT